Physician profile
Rodney Wilson Smith
NPI 1295787174
$3,371.74
in general payments reported to CMS, 2019-2025
25 companies · $33.10 in 2025
The $33.10 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $83.88 · 2021: $424 · 2022: $561 · 2023: $1,246 · 2024: $34.49 · 2025: $33.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,059 · Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,059.41 |
| Food and Beverage | $254.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,351.91 | 2021-2023 | Urolift |
| Astellas Pharma US INC | $543.92 | 2019-2020 | |
| Procept Biorobotics Corporation | $240.41 | 2022 | |
| Medtronic, INC. | $240.05 | 2021-2022 | |
| Boston Scientific Corporation | $160.56 | 2019-2022 | |
| Clarus Therapeutics INC. | $114.99 | 2021 | |
| Neotract INC. | $106.42 | 2019-2020 | |
| Antares Pharma, INC. | $95.16 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $83.15 | 2019-2023 | Xiaflex |
| Abbvie INC. | $67.59 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $52.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2022 | |
| Cook Medical LLC | $34.20 | 2019 | |
| Dendreon Pharmaceuticals LLC | $29.65 | 2019 | |
| Dornier Medtech America, INC | $28.30 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.84 | 2019-2020 | |
| Blue Earth Diagnostics | $24.67 | 2019 | |
| Healthtronics Stone Solutions, LLC | $23.27 | 2021 | |
| Laborie Medical Technologies Corp. | $20.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.85 | 2019 | |
| Axonics, INC. | $17.76 | 2022 | |
| Duchesnay USA Incorporated | $17.05 | 2019 | |
| Zyla Life Sciences, INC. | $13.03 | 2019 | |
| Dentsply Ih INC. | $12.32 | 2019 | |
| Pfizer INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.